Detection of the mecA Gene and Its Association With Antimicrobial Resistance Among Coagulase-Negative Staphylococci

Vanlal Tluanpuii1, Rakesh K Mahajan1

  • 1Microbiology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, IND.

Cureus
|May 5, 2025
PubMed

Insights

Coagulase-negative staphylococci (CoNS) frequently carry the mecA gene, leading to methicillin resistance. Combining mecA gene detection with cefoxitin disk diffusion improves accuracy in identifying resistant CoNS for better treatment decisions.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Coagulase-negative staphylococci (CoNS) are significant pathogens.
  • The mecA gene confers methicillin resistance in CoNS by encoding penicillin-binding protein 2a (PBP2a).
  • Methicillin-resistant CoNS (MR-CoNS) present a growing clinical challenge.

Purpose of the Study:

  • To determine the prevalence of the mecA gene in CoNS isolates.
  • To assess the correlation between mecA gene presence and antimicrobial resistance patterns.
  • To evaluate diagnostic approaches for MR-CoNS detection.

Main Methods:

  • Cross-sectional observational study of 100 CoNS isolates from a tertiary care hospital in Delhi, India.
  • Species identification using conventional methods and Vitek-2 ID system.
  • Antibiotic susceptibility testing via Kirby-Bauer disk diffusion and vancomycin E-test.
  • mecA gene detection using real-time polymerase chain reaction (rt-PCR).

Main Results:

  • Staphylococcus haemolyticus was the most common CoNS species (44%).
  • 82% of CoNS isolates were positive for the mecA gene.
  • Significant discrepancies were observed between cefoxitin disk diffusion results and mecA gene presence.

Conclusions:

  • The mecA gene is highly prevalent in CoNS isolates.
  • Cefoxitin disk diffusion alone may not accurately identify all MR-CoNS.
  • Combined mecA gene detection and cefoxitin disk diffusion are recommended for accurate MR-CoNS diagnosis and timely therapeutic decisions.